nitazoxanide / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nitazoxanide / Generic mfg.
ACTRN12614000381684: A randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Indigenous children

Terminated
4
300
 
Telethon Kids Institute, National Health and Medical Research Council, CentreCorp Foundation
Acute Gastroenteritis
 
 
NILE, NCT05184491: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Recruiting
4
500
RoW
Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL therapy, Treatment-experienced patients- LNDL therapy, Treatment-experienced patients- MNDL therapy
National Liver Institute, Egypt, Future pharmaceutical industries
Helicobacter Pylori
02/22
03/22
PENTZ, NCT04788407: Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts

Recruiting
4
456
RoW
Nitazoxanide, Nixoran, Placebo
Fundación Huésped, Ministerio de Salud de Ciudad Autónoma de Buenos Aires, Laboratorios Roemmers S.A.I.C.F.
Covid19, SARS-CoV-2 Infection, Households Contacts
04/22
04/22

Download Options